Beaufort’s Robert Di Tullio Will Kick Off AMDM 2016 IVD Focus Meeting
The Association of Medical Diagnostics Manufacturers (AMDM) will hold its 2016 IVD Focus Meeting October 13 and 14 in Los Gatos, Calif. Beaufort’s Robert Di Tullio, Sr., VP, Global Regulatory Services, will present an industry update on October 13 from 9:00 to 9:30 a.m. Beaufort also will sponsor the 10:30 a.m. event break that same day and will exhibit throughout the meeting. Beaufort has proudly participated in AMDM meetings for more than five years.
During this year’s industry update, meeting attendees will hear Robert address several key issues facing the industry including:
- The impact of MDUFA IV
- Proposed changes to the Common Rule
- Software modifications to 510(k)
- Current landscape and next steps for Point of Care/CLIA Waiver
Robert is an accomplished regulatory affairs professional with 42 years’ experience in the in vitro diagnostics industry with the last 29 years in regulatory, clinical and quality management. Prior to joining Beaufort, he was Vice President of Global Regulatory and Clinical Affairs for Alere and held similar positions at ProteoGenix, Sequenom, Siemens Medical Solutions Diagnostics and Diagnostic Products Corporation.
Robert’s April 2015 presentation, “The Changing Regulatory and Policy Environment for Diagnostics: What to Expect in 2015 & Beyond,” given at the AMDM 2015 Annual Meeting can be viewed here.
Beaufort, LLC, is a contract research organization that provides in vitro diagnostic, medical device and biopharmaceutical clinical and regulatory services, and a full range of quality solutions and staffing solutions. For more than a decade, companies worldwide have trusted Beaufort for its client-oriented approach to research. With operations spanning the globe, Beaufort has a proven track record working closely with clients and regulatory agencies internationally to bring our clients’ products to market. Learn more at BeaufortCRO.com.